Convergence Financial, LLC Novo Nordisk A S Transaction History
Convergence Financial, LLC
- $582 Billion
- Q2 2025
A detailed history of Convergence Financial, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Convergence Financial, LLC holds 13,245 shares of NVO stock, worth $659,336. This represents 0.16% of its overall portfolio holdings.
Number of Shares
13,245
Previous 12,521
5.78%
Holding current value
$659,336
Previous $869 Million
5.15%
% of portfolio
0.16%
Previous 0.17%
Shares
5 transactions
Others Institutions Holding NVO
# of Institutions
1,748Shares Held
332MCall Options Held
10.5MPut Options Held
16.2M-
Jennison Associates LLC18.9MShares$940 Million0.78% of portfolio
-
Bank Of America Corp Charlotte, NC14.8MShares$736 Million0.08% of portfolio
-
Loomis Sayles & CO L P12.6MShares$626 Million1.12% of portfolio
-
Morgan Stanley New York, NY12.3MShares$613 Million0.06% of portfolio
-
Capital International Investors Los Angeles, CA11.6MShares$579 Million0.14% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $112B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...